Evidence map›Paper›PMID 34988201›Full record

ArticleAnnals of translational medicine2021

Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinoma.

Ran Xu, Tong Lu, Jiaying Zhao, Qi Li, Jun Wang, Bo Peng, Jian Liu, Pengfei Zhang, Lidong Qu, Xiaoyan Chang and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ran XuDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Tong LuDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiaying ZhaoDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Qi LiDepartment of Child and Adolescent Health, School of Public Health, Harbin Medical University, Harbin, China.
Jun WangDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Bo PengDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jian LiuDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Pengfei ZhangDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lidong QuDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaoyan ChangDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lingqi YaoDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Linyou ZhangDepartment of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is a malignant disease with the highest cancer-related mortality rate. In lung adenocarcinoma (LUAD), protein ubiquitination can regulate multiple biological processes. A LUAD ubiquitylome analysis has not yet been reported.

methodsWe used for the first time ion mobility into liquid chromatography-mass spectrometry to perform accurate and reliable ubiquitylome and proteomic analysis of clinical LUAD and normal tissues and combined it with transcriptome data obtained from public databases. Ubiquitinated protein substrates and their gene expression pattern landscapes in LUAD were identified using bioinformatics methods.

resultsOur data revealed a ubiquitination landscape in LUAD and identified characteristic protein ubiquitination motifs. We found that the ubiquitinated peptide motifs in LUAD were completely different from those of previously published lung squamous cell carcinoma (LUSC). Moreover, we identified two gene expression patterns of ubiquitinated proteins and revealed that survival differences between these patterns may be correlated with the tumor immune infiltrating microenvironment. Finally, we constructed a prognostic predictive model to quantify the relationship between expression patterns and survival. We found a relationship between the patient-applied model score and multiple drug sensitivity. Therefore, our model can serve as a guide for LUAD clinical treatment.

conclusionsOur work addresses the lack of ubiquitylome studies in LUAD and provides new perspectives for subsequent research and clinical treatment.

Indexed as

Lung adenocarcinoma (LUAD)prognosisproteasomeproteomicubiquitylome

Identifiers

PMID34988201
PMCPMC8667112
OpenAlexW3217058892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.